Using “Big Data” in the cost-effectiveness analysis of next-generation sequencing technologies: Challenges and potential solutions
Next-generation sequencing (NGS) is considered to be a prominent example of “big data” because of the quantity and complexity of data it produces and because it presents an opportunity to use powerful information sources that could reduce clinical and health economic uncertainty at a patient level....
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Elsevier
2018
|